World leading authorities steeped in scientific excellence.
Dr Steven Chance (CEO & Co-Founder) has 20 years combined pathology and neuroscience experience researching the microscopic basis of brain disease. He is a world authority on the cortical disarray in dementia that is assessed by Cortical Disarray Measurement (CDM) technology.
Professor Mark Jenkinson (Co-Founder) is at the University of Oxford and is one of the architects of the world’s leading MRI analysis software suite (FSL). He is one of the highest cited MRI authors globally and is editor of a new series of books on MR imaging.
Cortical Disarray Measurement (CDM) is our core platform technology, initially applied to the diagnosis of Alzheimer’s disease but with the potential to be used to identify other brain conditions. We take measurements directly from standard MRI/DTI data and provide an index of the micro-anatomical health of patients’ brain circuits.